HROW Harrow Health, Inc.
Healthcare$34.17+3.55%ClosedMarket Cap: $1.27B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
42.80
P/S
4.58
EV/EBITDA
35.97
DCF Value
$-377.39
FCF Yield
1.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.1%
Operating Margin
10.5%
Net Margin
-5.6%
ROE
-33.7%
ROA
-3.6%
ROIC
8.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $44.2M | 61.2% | $-22.1M | $-27.6M | $— | — |
| Q4 null | $89.1M | 79.3% | $24.0M | $6.6M | $— | — |
| FY null | $272.3M | 75.1% | $38.6M | $-5.1M | $— | — |
| Q3 null | $71.6M | 75.3% | $14.7M | $1.0M | $— | — |
| Q2 null | $63.7M | 74.5% | $11.4M | $5.0M | $— | — |
| Q1 null | $47.8M | 67.5% | $-11.2M | $-17.8M | $— | — |
| Q4 null | $66.8M | 78.8% | $12.9M | $6.8M | $— | — |
| FY null | $199.6M | 75.3% | $8.8M | $-17.5M | $— | — |
| Q3 null | $49.3M | 75.6% | $1.3M | $-4.2M | $— | — |
| Q2 null | $48.9M | 74.4% | $1.5M | $-6.5M | $— | — |
| Q1 null | $34.6M | 69.5% | $-6.9M | $-13.6M | $— | — |
| Q4 2023 | $36.4M | 68.9% | $-4.9M | $-9.1M | $-0.26 | — |